Strive SEC Filings

Strive, Inc. released a Rule 425 communication regarding its proposed business combination with Semler Scientific. The message, posted by Strive’s CEO on X, reiterates cautionary forward‑looking statements.

Strive has filed a Registration Statement on Form S-4 to register the Class A common stock to be issued in connection with the transaction. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. Investors are urged to read these materials when available on the SEC’s website. The communication also states it is not an offer to sell or solicit the purchase of securities.

Strive, Inc. (ASST) filed a Form 8-K to provide materials related to its pending all-stock acquisition of Semler Scientific. The filing includes Semler’s interim unaudited condensed consolidated financial statements (Exhibit 99.1) and unaudited pro forma combined financial statements (Exhibit 99.2).

The boards of both companies unanimously approved the Merger Agreement on September 21, 2025. The pro formas present the combined statement of operations as if the merger occurred on January 1, 2024 and the combined statement of financial condition as of September 30, 2025, with adjustments and assumptions described in the exhibits. Strive has also filed a Form S-4 to register the Class A common stock to be issued in the transaction, and a definitive information statement/proxy statement/prospectus will be sent to Semler stockholders.

Strive, Inc. (ASST) reported third‑quarter results reflecting its transition to a bitcoin‑treasury asset manager. For the Successor period from September 12–30, 2025, Strive posted a net loss of $192.3 million, driven by a $140.8 million goodwill and intangible impairment and $24.9 million losses on digital assets and derivatives, on $0.3 million in revenue. Operating expenses were $19.5 million, including $16.3 million of share‑based compensation.

At September 30, assets totaled $792.6 million, including $672.9 million of digital assets at fair value (about 5,886 bitcoin with a $683.0 million aggregate cost). Cash was $109.1 million; equity was $779.4 million; liabilities were $13.1 million.

The company closed a $749.6 million PIPE on September 12 (Class A shares plus pre‑funded and traditional warrants) and raised $59.2 million via its at‑the‑market program. Subsequent events: purchase of 1,639.4 bitcoin for $170.2 million, $14.9 million of warrant‑exercise proceeds, and a $149.3 million IPO of variable‑rate preferred (SATA). As of November 7, 2025, shares outstanding were 592,579,510 Class A and 222,904,100 Class B.

Strive, Inc. furnished an 8‑K to announce that it issued a press release with financial results for the quarter ended September 30, 2025. The press release is included as Exhibit 99.1 and dated November 14, 2025.

The company states the Item 2.02 information, including Exhibit 99.1, is furnished and not deemed filed under Section 18 of the Exchange Act or incorporated by reference except as expressly provided. The report was signed by Chief Executive Officer Matthew Cole.

Strive, Inc. reposted a communication on X from board member Pierre Rochard regarding its proposed business combination with Semler Scientific (SMLR). The notice reiterates forward‑looking statement cautions and points investors to SEC filings for details.

Strive has filed a Form S-4 to register Class A common stock to be issued in connection with the transaction, which will include an information statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The communication also outlines where to access the S-4, related amendments, and future materials, and clarifies that this is not an offer to sell or solicit securities.

Strive, Inc. released a communication under Rule 425 about its proposed business combination with Semler Scientific, Inc. (SMLR). The message includes a broad forward‑looking statements disclaimer highlighting uncertainties around timing, integration and expected strategic and financial benefits.

Strive has filed a Registration Statement on Form S‑4 that will include an information statement of Strive, a proxy statement of Semler Scientific and a prospectus of Strive. Semler Scientific stockholders will receive a definitive document to vote on the transaction, and investors are urged to read the Registration Statement and related materials when available on the SEC’s website. The communication also states it is not an offer or solicitation to sell securities.

Strive, Inc. issued a Rule 425 communication about its proposed business combination with Semler Scientific, Inc. (SMLR). Strive has filed a Form S-4 to register Class A common stock to be issued in the transaction, which will include an information statement for Strive, a proxy statement for Semler Scientific, and a prospectus for Strive.

A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The companies emphasize forward-looking statement cautions, outline where investors can access SEC filings, note that directors and officers may be participants in the proxy solicitation, and clarify that this communication is not an offer or solicitation.

Strive, Inc. reposted on X a communication about its proposed business combination with Semler Scientific (SMLR). The message includes a forward‑looking statements caution and notes that Strive has filed a Form S‑4 to register Class A common stock to be issued in the transaction.

A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler stockholders to seek their approval, and investors are urged to read these materials when available. Documents will be accessible free of charge on the SEC’s website and via company investor relations pages. The communication also states it is not an offer or solicitation to buy or sell securities.

Strive, Inc. filed a Rule 425 communication regarding its proposed business combination with Semler Scientific (SMLR), noting that CEO Matthew Cole reposted the communication on X.com on November 12, 2025.

Strive has filed a Form S-4 registration statement to register Class A common stock to be issued in connection with the transaction. The S-4 will include an information statement/proxy statement/prospectus, and a definitive version will be sent to Semler stockholders to seek approval of the proposed transaction.

The notice includes extensive forward‑looking statement disclaimers and directs investors to read the S-4 and related materials when available, which will be accessible free of charge on the SEC’s website and the companies’ investor sites.